Altering BDNF expression by genetics and/or environment: Impact for emotional and depression-like behaviour in laboratory mice

被引:98
作者
Chourbaji, Sabine [1 ]
Brandwein, Christiane [1 ]
Gass, Peter [1 ]
机构
[1] Univ Heidelberg, Cent Inst Mental Hlth Mannheim ZI, D-6900 Heidelberg, Germany
关键词
BDNF; Mutant mice; Environment; Enrichment; Depression; Stress; Emotional behaviour; NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR EXPRESSION; ELEMENT-BINDING PROTEIN; FACTOR MESSENGER-RNA; CHRONIC ANTIDEPRESSANT TREATMENT; CHRONIC MILD STRESS; RAT-BRAIN; ENRICHED-ENVIRONMENT; TRANSGENIC MICE; HOUSING CONDITIONS;
D O I
10.1016/j.neubiorev.2010.07.003
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
010107 [宗教学]; 030301 [社会学]; 070906 [古生物学及地层学(含古人类学)];
摘要
According to the "neurotrophin hypothesis", brain-derived neurotrophic factor (BDNF) is an important candidate gene in depression. Moreover, environmental stress is known to represent a risk factor in the pathophysiology and treatment of this disease. To elucidate, whether changes of BDNF availability signify cause or consequence of depressive-like alterations, it is essential to look for endophenotypes under distinct genetic conditions (e.g. altered BDNF expression). Furthermore it is crucial to examine environment-driven BDNF regulation and its effect on depressive-linked features. Consequently, gene x environment studies investigating prospective genetic mouse models of depression in different environmental contexts become increasingly important. The present review summarizes recent findings in BDNF-mutant mice, which have been controversially discussed as models of depression and anxiety. It furthermore illustrates the potential of environment to serve as naturalistic stressor with the potential to modulate the phenotype in wildtype and mutant mice. Moreover, environment may exert protective effects by regulating BDNF levels as attributed to "environmental enrichment". The effect of this beneficial condition will also be discussed with regard to probable "curative/therapeutic" approaches. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:599 / 611
页数:13
相关论文
共 156 条
[1]
Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy [J].
Adachi, Megumi ;
Barrot, Michel ;
Autry, Anita E. ;
Theobald, David ;
Monteggia, Lisa M. .
BIOLOGICAL PSYCHIATRY, 2008, 63 (07) :642-649
[2]
Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways [J].
Almeida, RD ;
Manadas, BJ ;
Melo, CV ;
Gomes, JR ;
Mendes, CS ;
Graos, MM ;
Carvalho, RF ;
Carvalho, AP ;
Duarte, CB .
CELL DEATH AND DIFFERENTIATION, 2005, 12 (10) :1329-1343
[3]
Neurotrophins and depression [J].
Altar, CA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (02) :59-61
[4]
Angelucci F, 2000, J NEUROSCI RES, V60, P783, DOI 10.1002/1097-4547(20000615)60:6<783::AID-JNR11>3.0.CO
[5]
2-M
[6]
Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regions [J].
Angelucci, F ;
Aloe, L ;
Gruber, SHM ;
Fiore, M ;
Mathé, AA .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2000, 3 (01) :13-25
[7]
Neurotrophin signaling:: many exciting surprises! [J].
Arevalo, J. C. ;
Wu, S. H. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (13) :1523-1537
[8]
Gender-Specific Impact of Brain-Derived Neurotrophic Factor Signaling on Stress-Induced Depression-Like Behavior [J].
Autry, Anita E. ;
Adachi, Megumi ;
Cheng, Pengfei ;
Monteggia, Lisa M. .
BIOLOGICAL PSYCHIATRY, 2009, 66 (01) :84-90
[9]
Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist [J].
Barrientos, RM ;
Sprunger, DB ;
Campeau, S ;
Higgins, EA ;
Watkins, LR ;
Rudy, JW ;
Maier, SF .
NEUROSCIENCE, 2003, 121 (04) :847-853
[10]
Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder [J].
Bayer, TA ;
Schramm, M ;
Feldmann, N ;
Knable, MB ;
Falkai, P .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2000, 24 (06) :881-888